YAP activates the PI3K-AKT pathway via its direct target Pik3cb to regulate cardiomyocyte proliferation and survival, with Pik3cb expression rescuing impaired heart function in YAP loss-of-function.
The study identifies Pik3cb as a critical link between the Hippo-YAP and PI3K-AKT pathways, driving cardiomyocyte proliferation and survival, offering potential molecular targets for cardiac regeneration.
RATIONALE: Yes-associated protein (YAP), the nuclear effector of Hippo signaling, regulates cellular growth and survival in multiple organs, including the heart, by interacting with TEA (transcriptional enhancer activator)-domain sequence-specific DNA-binding proteins. Recent studies showed that YAP stimulates cardiomyocyte proliferation and survival. However, the direct transcriptional targets through which YAP exerts its effects are poorly defined. OBJECTIVE: To identify direct YAP targets that mediate its mitogenic and antiapoptotic effects in the heart. METHODS AND RESULTS: We identified direct YAP targets by combining differential gene expression analysis in YAP gain- and loss-of-function with genome-wide identification of YAP-bound loci using chromatin immunoprecipitation and high throughput sequencing. This screen identified Pik3cb, encoding p110β, a catalytic subunit of phosphoinositol-3-kinase, as a candidate YAP effector that promotes cardiomyocyte proliferation and survival. YAP and TEA-domain occupied a conserved enhancer within the first intron of Pik3cb, and this enhancer drove YAP-dependent reporter gene expression. Yap gain- and loss-of-function studies indicated that YAP is necessary and sufficient to activate the phosphoinositol-3-kinase-Akt pathway. Like Yap, Pik3cb gain-of-function stimulated cardiomyocyte proliferation, and Pik3cb knockdown dampened YAP mitogenic activity. Reciprocally, impaired heart function in Yap loss-of-function was significantly rescued by adeno-associated virus-mediated Pik3cb expression. CONCLUSIONS: Pik3cb is a crucial direct target of YAP, through which the YAP activates phosphoinositol-3-kinase-AKT pathway and regulates cardiomyocyte proliferation and survival.
Lin et al. (Wed,) conducted a other in Cardiomyocyte proliferation and survival. YAP and Pik3cb gain- and loss-of-function was evaluated on Cardiomyocyte proliferation and survival. YAP activates the PI3K-AKT pathway via its direct target Pik3cb to regulate cardiomyocyte proliferation and survival, with Pik3cb expression rescuing impaired heart function in YAP loss-of-function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: